Item 5.02 Departure of Directors or Certain Officers;
Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On January 14, 2013, Dr. Christopher McGuigan was appointed as a Director of Trovagene, Inc. (the "Company") to serve until the next election of directors by the stockholders and until the election and qualification of his successor. Dr. McGuigan was nominated for the position by the Corporate Governance/Nominating Committee of the Board of Directors.

Since 1995, Dr. McGuigan has been Professor, Welsh School of Pharmacy, Head of Medicinal Chemistry, at Cardiff University, UK. In 2011 he was appointed Deputy Pro Vice Chancellor to the University and in 2012 he was appointed Pro Vice Chancellor. He is also a member of the Editorial Board for the Journal of Molecular Pharmaceutics and is the past President of the International Society for Antiviral Research. Dr. McGuigan is a director of Synergy Pharmaceuticals Inc., a biotechnology company. Dr. McGuigan received a B.S. and Ph.D. in Anticancer Drug Design from the University of Birmingham.